0000950170-24-001969.txt : 20240104
0000950170-24-001969.hdr.sgml : 20240104
20240104164019
ACCESSION NUMBER: 0000950170-24-001969
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trost Timothy W.
CENTRAL INDEX KEY: 0001571865
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40366
FILM NUMBER: 24512681
MAIL ADDRESS:
STREET 1: C/O CHIMERIX, INC.
STREET 2: 2505 MERIDIAN PARKWAY, SUITE 340
CITY: DURHAM
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Werewolf Therapeutics, Inc.
CENTRAL INDEX KEY: 0001785530
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 823523180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TALCOTT AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-952-0555
MAIL ADDRESS:
STREET 1: 200 TALCOTT AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
ownership.xml
4
X0508
4
2024-01-02
0001785530
Werewolf Therapeutics, Inc.
HOWL
0001571865
Trost Timothy W.
C/O WEREWOLF THERAPEUTICS, INC.
200 TALCOTT AVENUE, 2ND FLOOR
WATERTOWN
MA
02472
false
true
false
false
Chief Financial Officer
false
Stock Option (right to buy)
4.64
2024-01-02
4
A
false
150000
0.00
A
2033-12-31
Common Stock
150000
150000
D
The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028.
/s/ Jonathan Owen, Attorney-in-fact
2024-01-04